Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Chronic Hepatitis C Who Have Not Achieved an Undetectable HCV RNA Level With Previous Interferon Based Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Vertex Pharmaceuticals Incorporated
Related studies linked through entity extraction aliases.
Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Chronic Hepatitis C Who Relapsed After Previous Interferon Based Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of MP-424/Peginterferon Alfa-2b/Ribavirin Combination in Treatment-Naïve Patients With Chronic Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE3
A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 1 Study of MP-424, Peginterferon Alfa 2b, and Ribavirin in Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 3 Study of Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 Hepatitis C Virus (HCV)
- Status
- COMPLETED
- Phase
- PHASE3
Safety,Tolerability and Pharmacokinetics of Multiple Ascending Doses of VCH 916 in Subjects With Chronic Hep C Infection
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of MP-424 to Treat Chronic Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE2
Safety and PK Study of MP-424 to Treat Chronic Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE1
A Rollover Study for Subjects Participating in the Control Arm of Study VX06-950-106, VX05-950-104 and VX05-950-104EU Whose Plasma Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) Levels Did Not Respond to Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Study of Telaprevir in Subjects With Hepatic Impairment
- Status
- COMPLETED
- Phase
- PHASE1
A Safety Study for Cethrin (BA-210) in the Treatment of Acute Thoracic and Cervical Spinal Cord Injuries
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study of Ivacaftor in Subjects With Cystic Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Telaprevir (VX-950), Pegasys and Copegus in Hepatitis C (PROVE3)
- Status
- COMPLETED
- Phase
- PHASE2
A Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702
- Status
- COMPLETED
- Phase
- PHASE2
A Proof-of-concept Study of VCH-759 for the Treatment of Hepatitis C-infection.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 2 Study of VX-950, Pegasys® With and Without Copegus® in Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE2
Trial of AVN-944 in Patients With Advanced Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1